Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis. by Urs B Hagemann, Lavinia Gunnarsson, Solène Géraudie, Ulrike Scheffler, Remko A Griep, Herald Reiersen, Alexander R Duncan, Sergej M Kiprijanov

Get full text

Targeted thorium-227 conjugates as treatment options in oncology by Jenny Karlsson, Christoph A. Schatz, Antje M. Wengner, Stefanie Hammer, Arne Scholz, Alan Cuthbertson, Volker Wagner, Hartwig Hennekes, Vicki Jardine, Urs B. Hagemann

Get full text

Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model by Katrine Wickstroem, Jenny Karlsson, Christine Ellingsen, Véronique Cruciani, Alexander Kristian, Urs B. Hagemann, Roger M. Bjerke, Olav B. Ryan, Lars Linden, Dominik Mumberg, Michael Brands, Alan Cuthbertson

Get full text

Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis Model by Jenny Karlsson, Urs B. Hagemann, Véronique Cruciani, Christoph A. Schatz, Derek Grant, Christine Ellingsen, Alexander Kristian, Shirin Katoozi, Dessislava Mihaylova, Steinar R. Uran, Mari Suominen, Roger M. Bjerke, Olav B. Ryan, Alan Cuthbertson

Get full text

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy by Pascale Lejeune, Véronique Cruciani, Axel Berg-Larsen, Andreas Schlicker, Anne Mobergslien, Lisa Bartnitzky, Sandra Berndt, Sabine Zitzmann-Kolbe, Claudia Kamfenkel, Stefan Stargard, Stefanie Hammer, Jennifer S Jørgensen, Malene Jackerott, Carsten H Nielsen, Christoph A Schatz, Hartwig Hennekes, Jenny Karlsson, Alan S Cuthbertson, Dominik Mumberg, Urs B Hagemann

Get full text